Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on GSK2190915 versus placebo, montelukast, or salmeterol with fluticasone propionate in uncontrolled asthma
2010-019466-81Phase 2
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fiboflapon in asthma (5 arms), sponsored by GSK. Primary endpoint: Trough forced expiratory volume in 1 second.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-019466-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019466-81.